v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2023 $ 116,252   $ 4 $ 339,025 $ (5) $ (222,772)
Beginning balance, Shares at Dec. 31, 2023     35,884,712      
Issuance of common stock, net of issuance costs 5,183     5,183    
Issuance of common stock, net of issuance costs, shares     1,699,600      
Stock-based compensation 2,312     2,312    
Unrealized gain (loss) on available for sale securities (25)       (25)  
Net loss (19,940)         (19,940)
Balance at Mar. 31, 2024 103,782   $ 4 346,520 (30) (242,712)
Ending balance shares at Mar. 31, 2024     37,584,312      
Balance at Dec. 31, 2023 116,252   $ 4 339,025 (5) (222,772)
Beginning balance, Shares at Dec. 31, 2023     35,884,712      
Balance at Dec. 31, 2024 $ 71,635   $ 4 378,632 27 (307,028)
Temporary equity balance, shares at Dec. 31, 2024   537,634        
Ending balance shares at Dec. 31, 2024 40,886,762   40,886,762      
Issuance of common stock, net of issuance costs $ 13,267   $ 1 13,266    
Issuance of common stock, net of issuance costs, shares     5,784,772      
Stock-based compensation 2,642     2,642    
Unrealized gain (loss) on available for sale securities (8)       (8)  
Net loss (22,413)         (22,413)
Balance at Mar. 31, 2025 $ 65,123   $ 5 $ 394,540 $ 19 $ (329,441)
Temporary equity balance, shares at Mar. 31, 2025   537,634        
Ending balance shares at Mar. 31, 2025 46,671,534   46,671,534